Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Pediatr Surg Int ; 39(1): 247, 2023 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-37584865

RESUMO

PURPOSE: Urological management of Cloacal Malformation (CM) focuses on preserving renal function and continence. Study aim was to analyze urinary and intestinal outcomes in CM patients, considering the length of common channel (CC) and presence of occult spinal dysraphism (OSD). METHODS: Retrospective review of CM treated at our institution by a multidisciplinary team from 1999 to 2020. Patients with follow-up < 2.5 years were excluded. Length of CC, renal function, urinary and bowel outcomes, presence of associated anomalies (especially OSD) were evaluated. RESULTS: Twenty patients were included, median age at follow-up: 8 years (4-15). A long CC > 3 cm was described in 11 (55%). Chronic kidney disease was found in 3 patients. Urinary continence was achieved in 8/20 patients, dryness (with intermittent catheterization) in 9/20. Fecal continence was obtained in 3/20, cleanliness in 14 (under bowel regimen). OSD was present in 10 patients (higher prevalence in long-CC, 73%). Among OSD, 1 patient reached fecal continence, 7 were clean; 2 achieved urinary continence, while 6 were dry. CONCLUSIONS: Length of CC and OSD may affect urinary and fecal continence. An early counseling can improve outcome at long-term follow-up. Multidisciplinary management with patient centralization in high grade institutions is recommended to achieve better results.


Assuntos
Defeitos do Tubo Neural , Incontinência Urinária , Humanos , Animais , Pré-Escolar , Criança , Adolescente , Cloaca/anormalidades , Intestino Grosso , Urodinâmica , Estudos Retrospectivos
2.
Dis Esophagus ; 26(4): 388-91, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23679029

RESUMO

Esophageal stenting represents a new strategy in the treatment of resistant or recurrent stenosis that obviates the need for multiple dilations. Our custom dynamic stent (DS) improves esophageal motility unlike the widespread self-expandable plastic or metallic esophageal stents. The DS allows food and secretions to pass in the space between the esophageal wall and the stent wall. This contrasts with the other types of stent, in which food passes into the stent that presses into the esophageal wall. Until the stent patent is complete, we use slices of silicon drains overlapped with each other to fashion the stent to the desired length and diameter (7-, 9-, or 12.7-mm external diameter). It is built coaxially on a nasogastric tube that guarantees the correct position. The two ends are tailored to allow an easy introduction and food passage between stent and esophageal wall. The stent is inserted after stricture dilations (Savary-Gilliard dilators) under fluoroscopic guidance. All patients who underwent stenting were treated with dexamethasone (2 mg/kg/day) for 3 days and proton pump inhibitors (omeprazole or lansoprazole, 1-2 mg/kg/day). From 1992 to 2012, 387 patients (mean age 38.6 months; range 3-125 months) with post-surgical esophageal stricture because of esophageal atresia correction were enrolled in this study. Twenty-six of 387 patients (6.7%) underwent custom DS placement for recurrent stricture instead of a program of serial dilations. The stent was left in place for at least 40 days and was effective in 21 (80.7%) of 26 patients. There were two stent-related major complications (subclavian-esophageal fistula). Our custom stent represents an effective and safe option in the treatment of severe and recurrent post-surgical esophageal strictures. Surgery with stricture resection, and reanastomosis or jeunoplasty represents the rescue strategy.


Assuntos
Atresia Esofágica/cirurgia , Estenose Esofágica/terapia , Complicações Pós-Operatórias/terapia , Stents , Criança , Pré-Escolar , Estenose Esofágica/etiologia , Esofagoscopia , Fluoroscopia , Humanos , Lactente , Recidiva , Estudos Retrospectivos , Resultado do Tratamento
3.
Dig Liver Dis ; 38(4): 245-51, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16198647

RESUMO

UNLABELLED: Eosinophilic oesophagitis is an emerging disease, well known also in paediatric age, probably caused by both IgE and non-IgE mediated food allergies, diagnosed by upper endoscopy with biopsy. The most severe complication is oesophageal stenosis. The identification of the offending allergens is often difficult; therapy is focused to eliminate the supposed antigenic stimulus, to control the acute symptoms and to induce long-term remission. AIM: We report the clinical outcome and the typical endoscopic findings of children and adolescents affected by eosinophilic oesophagitis, referring a proposal of diagnostic and treatment protocol. PATIENTS AND METHODS: Twelve patients, affected by eosinophilic oesophagitis with a histological diagnosis, underwent radiographic upper gastro-intestinal series, 24 h pH-probe and standardised allergic testing; they were treated with steroids (oral prednisone and swallowed aerosolised fluticasone) and elimination diet. Dilations were performed when eosinophilic oesophagitis was not yet diagnosed, or in patients resistant to conventional treatment. RESULTS: Two patients were lost to follow up (mean follow up: 1 year 11 months); seven patients have no symptoms and normal histology, five of them on restricted diet (without cow's milk protein) and two patients on elemental diet (amino acid formula). In two patients (no allergens identified), mild dysphagia and eosinophilic infiltration persist; one patients underwent Nissen fundoplication for Barrett's oesophagus: he has no symptoms and normal oesophagus, on restricted diet (without cow's milk/eggs protein and wheat). CONCLUSION: The recognition of typical endoscopic picture with careful biopsies extended to the whole oesophagus, even in emergency, could more quickly lead to the correct diagnosis and avoid severe complications of eosinophilic oesophagitis in children, as stricture and failure to growth. Elimination diet is the key of resolution when the allergens are identified. A great challenge remains the relation between gastro-oesophageal reflux disease and eosinophilic oesophagitis, which should however be explained.


Assuntos
Eosinofilia/diagnóstico , Eosinofilia/terapia , Esofagite/diagnóstico , Esofagite/terapia , Hipersensibilidade Alimentar/complicações , Administração por Inalação , Administração Oral , Adolescente , Aerossóis , Androstadienos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Biópsia , Cateterismo , Criança , Pré-Escolar , Endoscopia do Sistema Digestório , Eosinofilia/etiologia , Monitoramento do pH Esofágico , Esofagite/etiologia , Feminino , Fluticasona , Hipersensibilidade Alimentar/diagnóstico , Hipersensibilidade Alimentar/terapia , Humanos , Imunoglobulina E/sangue , Lactente , Masculino , Prednisona/uso terapêutico , Estudos Prospectivos , Estudos Retrospectivos , Testes Cutâneos , Trato Gastrointestinal Superior/patologia
4.
J Crohns Colitis ; 9(7): 558-64, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25895877

RESUMO

BACKGROUND AND AIMS: Recent epidemiological studies showed an increase in ulcerative colitis among children, especially in its aggressive form, requiring surgical treatment. Although medical therapeutic strategies are standardized, there is still no consensus regarding indications, timing and kind of surgery. This study aimed to define the surgical management of paediatric ulcerative colitis and describe attitudes to it among paediatric surgeons. METHODS: This was a retrospective cohort study. All national gastroenterology units were invited to participate. From January 2009 to December 2013, data on paediatric patients diagnosed with ulcerative colitis that required surgery were collected. RESULTS: Seven units participated in the study. Seventy-one colectomies were performed (77.3% laparoscopically). Main surgical indications were a severe ulcerative colitis attack (33.8%) and no response to medical therapies (56.3%). A three-stage strategy was chosen in 71% of cases. Straight anastomosis was performed in 14% and J-pouch anastomosis in 86% of cases. A reconstructive laparoscopic approach was used in 58% of patients. Ileo-anal anastomosis was performed by the Knight-Griffen technique in 85.4% and by the pull-through technique in 9.1% of patients. Complications after colectomy, after reconstruction and after stoma closure were reported in 12.7, 19.3 and 35% of cases, respectively. CONCLUSIONS: This study shows that there is general consensus regarding indications for surgery. The ideal surgical technique remains under debate. Laparoscopy is a procedure widely adopted for colectomy but its use in reconstructive surgery remains limited. Longer follow-up must be planned to define the quality of life of these patients.


Assuntos
Atitude do Pessoal de Saúde , Colite Ulcerativa/cirurgia , Gastroenterologia , Proctocolectomia Restauradora/métodos , Adolescente , Criança , Pré-Escolar , Colite Ulcerativa/tratamento farmacológico , Colostomia/efeitos adversos , Defecação , Resistência a Medicamentos , Incontinência Fecal/etiologia , Feminino , Humanos , Itália , Masculino , Pouchite/etiologia , Proctocolectomia Restauradora/efeitos adversos , Estudos Retrospectivos , Índice de Gravidade de Doença
7.
Expert Opin Pharmacother ; 9(5): 731-40, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18345951

RESUMO

Eosinophilic esophagitis represents the most debated disease of the last 10 years, too often speculated or overestimated and certainly well known and examined. The aim of this study was to summarize the recent therapeutic trends in order to show persistent doubts regarding several debated therapies. The study combined the most recent international literature and the authors' daily experience to define the scope of the review, with limits caused by a lack of available randomized studies between dietetic and pharmacological treatment. It was concluded that eosinophilic esophagitis is an immunoallergic disease that is generally caused by identifiable food and environmental allergens although, in a minority of cases, the etiological trigger remains undetermined. Therapy usually fights the responsible agents, but sometimes they are not resolved. A need for more pathogenetically driven treatments is invoked.


Assuntos
Anti-Inflamatórios/farmacologia , Eosinofilia/terapia , Esofagite/terapia , Adulto , Anti-Inflamatórios/uso terapêutico , Produtos Biológicos/farmacologia , Produtos Biológicos/uso terapêutico , Criança , Eosinofilia/diagnóstico , Eosinofilia/imunologia , Esofagite/diagnóstico , Esofagite/imunologia , Hipersensibilidade Alimentar/complicações , Glucocorticoides/farmacologia , Glucocorticoides/uso terapêutico , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA